The Aurum Institute - The Aurum Institute

A Mixed-Method Evaluation of the Association Between Attitudes Toward Gender-Based Violence and Sexual Behaviors Among Adolescents and Young Adults in Rustenburg, South Africa

2026-01-09T09:55:02+02:00

Makkan, H., Mlotshwa, M., Masibi, P., Molefe, T., Mthembu, F., Maenetje, P., Edward, V.A., Price, M.A., Chetty-Makkan, C., De Wit, J.B. and Lalla-Edward, S.T., 2026. A Mixed-Method Evaluation of the Association Between Attitudes Toward Gender-Based Violence and Sexual Behaviors Among Adolescents and Young Adults in Rustenburg, South Africa. AIDS and Behavior, pp.1-16.

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

2025-07-10T14:07:23+02:00

Koele, S.E., Stoycheva, K., Mtweve, C., Manyama, C., Mpagama, S., Mhimbira, F., Wallis, R., Ntinginya, N.E., Liyoyo, A., Huglin, B. and Minja, L.T., 2025. Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB. Journal of Antimicrobial Chemotherapy, p.dkaf210.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

2025-07-09T11:50:02+02:00

Minja, L.T., van der Feltz, I., Manyama, C., Mpagama, S., Mhimbira, F., Noreña, I., Sebe, M., Rassool, M., Wallis, R., Ntinginya, N.E. and Liyoyo, A., A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE.

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

2025-05-16T11:46:38+02:00

Weld, E.D., Beattie, T., Moodley, J., Mapendere, M., Salles, I., Solans, B.P., Nonyane, B.A., Wiesner, L., Nielson, T., Edward, V.A. and Chihota, V., 2025. Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. The Lancet HIV.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

2025-04-11T10:03:25+02:00

Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N.M., Andriesen, J., Takalani, A., Fisher, L.H., Kee, J.J. and Magaret, C.A., 2025. Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. EClinicalMedicine, 80.

Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review

2025-04-11T09:56:47+02:00

Chihota, V., Gombe, M., Gupta, A., Salazar-Austin, N., Ryckman, T., Hoffmann, C.J., LaCourse, S., Mathad, J.S., Mave, V., Dooley, K.E. and Chaisson, R.E., 2024. Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review. Drugs, pp.1-21.

“Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users

2025-04-11T09:54:48+02:00

Fargnoli, V., Hanh, H.T.M., Hoang, L.N., Mahesh, A., Mqedlana-Ntombela, N., Xavier, J., Kohli, M., Velen, K. and Shilton, S., 2025. “Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users. Tropical Medicine and Infectious Disease, 10(2), p.44.

BMI as a predictor of progression from TB infection to active TB in PLHIV.

2025-04-11T09:52:53+02:00

Nguenha, D., Ndebele, F., Saavedra, B., Mambuque, E., Acácio, S., Cárdenas, V., Chihota, V., Grant, A., Yimer, G., Fielding, K. and Cobelens, F., 2025. BMI as a predictor of progression from TB infection to active TB in PLHIV. The International Journal of Tuberculosis and Lung Disease, 29(2), pp.54-59.

The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.

2025-04-11T09:51:36+02:00

Sumner, T., Clark, R.A., Prys-Jones, T.O., Bakker, R., Churchyard, G. and White, R.G., 2022. The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa. AIDS, pp.10-1097.

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

2025-04-11T09:50:12+02:00

Mapamba, D.A., Sabi, I., Lalashowi, J., Sauli, E., Buza, J., Olomi, W., Mtafya, B., Kibona, M., Bakuli, A., Rachow, A. and Velen, K., 2025. N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis. Journal of Infection, 90(2), p.106379.